Mirion Announces First Quarter 2026 Financial Results
Mirion reported Q1 revenue of $257.6 million, up 27.5% year-over-year, driven by substantial orders growth in the nuclear power and cancer care end markets. Adjusted EBITDA increased 16.3% to $54.3 million, while the company recorded a GAAP net loss of $3.4 million compared to prior-year income due to acquisition-related costs.
Key figures
- Revenue
- $257.6 million
- Guidance
- 2026 Revenue growth 22.0%-24.0%; Organic growth 5.0%-7.0%; Adj EBITDA $285M-$300M; Adj EPS $0.48-$0.55 (down from $0.50-$0.57)
- Revenue Yoy
- 27.5%
- Adjusted eps
- 0.1
- Adjusted ebitda
- $54.3 million
- Orders excluding acq
- $241 million
- Orders including acq
- $288 million
- Adjusted ebitda margin
- 21.1%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.